The DOI matches its Crossref record; 270 of the 272 references it cites were found in a registry or an index.
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
Open accessAbstract
In 2019, an ‘influenza pandemic’ and ‘vaccine hesitancy’ were listed as two of the top 10 challenges to global health by the WHO. The skin is a unique vaccination site, due to its immune-rich milieu, which is evolutionarily primed to respond to challenge, and its ability to induce both humoral and cellular immunity. Vaccination into this dermal compartment offers a way of addressing both of the challenges presented by the WHO, as well as opening up avenues for novel vaccine formulation and dose-sparing strategies to enter the clinic. This review will provide an overview of the diverse range of vaccination techniques available to target the dermal compartment, as well as their current state, challenges, and prospects, and touch upon the formulations that have been developed to maximally benefit from these new techniques. These include needle and syringe techniques, microneedles, DNA tattooing, jet and ballistic delivery, and skin permeabilization techniques, including thermal ablation, chemical enhancers, ablation, electroporation, iontophoresis, and sonophoresis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The dermis has a rich network of dendritic cells, macrophages and T cells40.”
From An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial (2024) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,691
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
Lee, H., Choi, T. K., Lee, Y. B., Cho, H. R., Ghaffari, R., Wang, L., Choi, H. J., Chung, T. D., Lu, N., Hyeon, T., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.38 · Cited by 1,802
Williams, A. C., & Barry, B. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,518
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,365
Microneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,277
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., FULLER, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,116
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Prüss‐Üstün, A., Rapiti, E., & Hutin, Y. J. (2005) · American Journal of Industrial Medicine · doi:10.1002/ajim.20230 · Cited by 916
Research works printed but not linked: 6
- World Health Organization, and Program for Appropriate Technology in Health (PATH) (2009). Intradermal Delivery of Vaccines—A Review of the Literature and the Potential for Development for Use in Low and Middle Income Countries, Program for Appropriate Technology in Health (PATH).
- Tuft, 1931, Active immunization against typhoid fever, with particular reference to an intradermal method, J. Lab. Clin. Med., 16, 552
- Garg, 2012, An evolutionary approachs in development of needle free injection technologies, Int. J. Pharm. Pharm. Sci., 4, 590
- Palermo, 2018, Evaluation of a needle-free vaccine delivery device for vaccinating rats with rift valley fever vaccine candidates, Int. J. Vet. Sci., 7, 140
- Lademann, 2019, Importance of the follicular penetration path for drug delivery by means of nanocarriers, Dermatologist, 70, 185
- Smith, T.R.F., Ramos, S., Yang, M., Gary, E.N., Schultheis, K., Walker, S.N., Doan, A., and Vasquez, M. (2020). Rapid development of a synthetic DNA vaccine for COVID-19. Nat. Res. · DOI
Cited by
Sorted by citations
Jet injectors: Perspectives for small volume delivery with lasers
Schoppink, J. J., & Rivas, D. F. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114109 · Cited by 105
Iontophoresis-driven microneedle patch for the active transdermal delivery of vaccine macromolecules
Zheng, Y., Ye, R., Gong, X., Yang, J., Liu, B., Xu, Y., Nie, G., Xie, X., & Jiang, L. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00515-1 · Cited by 81
Byrne, J. D., Huang, H., McRae, J. C., Babaee, S., Soltani, A., Becker, S., & Traverso, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113926 · Cited by 79
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Kwon, M., Jung, H., Nam, G., & Kim, I.-S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.009 · Cited by 77
Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
Clemente, B., Denis, M., Silveira, C. P., Schiavetti, F., Brazzoli, M., & Stranges, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294929 · Cited by 71
Metadata
- Authors
- Hettinga, J., & Carlisle, R.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Carlisle, Robert
- Venue
- Vaccines
- Publisher
- MDPI AG
- Published
- 2020-09-16
- Volume
- 8
- Issue
- 3
- Pages
- 534
- ISSN
- 2076-393X (ISSN-L)
- PMC
- PMC7564253
- OpenAlex
- W3085198834
- Cited by
- 72
- References
- 272
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 8 · 2023: 20 · 2022: 12 · 2021: 9 · 2020: 1
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Vaccines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Engineering and Physical Sciences Research Council (EP/L016494/1)
- EPSRC Centre for Doctoral Training in Medical Imaging (EP/L024012/1)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
- Life Sciences › Immunology and Microbiology › Virology › Poxvirus research and outbreaks
- Keywords
- microneedles, electroporation, iontophoresis, sonophoresis, thermal ablation, vaccine formulation, humoral and cellular immunity, pandemic influenza, vaccine hesitancy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
